Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Brigatinib bulk supplier for pharma manufacturers

Brigatinib 30mg, 90mg, 180mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 30mg, 90mg, 180mg

Reference Brands: Alunbrig (USA)

Category: Oncology Cancer Care

Brigatinib is a tyrosine kinase inhibitor (TKI) used in the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC). It works by blocking abnormal ALK protein activity that promotes cancer cell growth. Brigatinib is available as oral film-coated tablets in 30 mg, 90 mg, and 180 mg strengths. It is prescribed as a targeted therapy for patients who have progressed on or are intolerant to other ALK inhibitors like crizotinib.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Brigatinib — third party manufacturing & bulk supply

Brigatinib 30mg, 90mg, 180mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Brigatinib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Brigatinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Brigatinib →
Back to Listing

Frequently Asked Questions

Brigatinib is listed as Tablets in 30mg, 90mg, 180mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Brigatinib is referenced against Alunbrig (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Copanlisib

Strength:
60 mg /vial

Form: Injection

Reference Brands: Aliqopa (USA/EU)

View Details
Alectinib

Strength:
150 mg

Form: Capsules

Reference Brands: Alecensa (USA/EU)

View Details
Niraparib+Abiraterone

Strength:
100mg+500mg / 200mg+1000mg

Form: Tablet

Reference Brands: AKEEGA (USA/EU)

View Details
Niraparib

Strength:
100 mg, 200 mg, 300 mg

Form: Capsule/ Tablet

Reference Brands: Zejula (USA/EU)

View Details
Octreotide Injection

Strength:
50 mcg/mL, 100 mcg/mL, 200,cg/mL, 500 mcg/mL

Form: Injection

Reference Brands: Sandostatin.(EU & US)

View Details
Ondansetron Injection

Strength:
2 mg/2 mL, 4 mg/2 mL , 8 mg/4 mL

Form: Injection

Reference Brands: Zofran(US & EU)

View Details
Oxaliplatin Injection

Strength:
50 mg/10 mL, 100 mg/20 mL, 200 mg/40 mL

Form: Solution for Injection

Reference Brands: Eloxatin(US & EU)

View Details
Megestrol Acetate

Strength:
20 mg, 40 mg, 160 mg, 625 mg

Form: Tablet

Reference Brands: Megace(US & EU), Megestat®, Megaplex®, Megacephin®(EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.